Cargando…

A novel anti‐c‐Kit antibody–drug conjugate to treat wild‐type and activating‐mutant c‐Kit‐positive tumors

c‐Kit overexpression and activating mutations, which are reported in various cancers, including gastrointestinal stromal tumor (GIST), small‐cell lung cancer (SCLC), acute myeloid leukemia, acral melanoma, and systemic mastocytosis (SM), confer resistance to tyrosine kinase inhibitors (TKIs). To ove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jin‐Ock, Kim, Kwang‐Hyeok, Baek, Eun Ji, Park, Bomi, So, Min Kyung, Ko, Byoung Joon, Ko, Han‐Jik, Park, Sang Gyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936518/ https://www.ncbi.nlm.nih.gov/pubmed/34407310 http://dx.doi.org/10.1002/1878-0261.13084

Ejemplares similares

Antibody-Drug Conjugate Targeting c-Kit for the Treatment of Small Cell Lung Cancer
por: Kim, Kwang-Hyeok, et al.
Publicado: (2022)

A fully human anti-c-Kit monoclonal antibody 2G4 inhibits proliferation and degranulation of human mast cells
por: Kim, Kwang-Hyeok, et al.
Publicado: (2022)

Pharmacological inhibitors of c-KIT block mutant c-KIT mediated migration of melanocytes and melanoma cells in vitro and in vivo
por: Posch, Christian, et al.
Publicado: (2016)

Protein tyrosine phosphatase receptor type E (PTPRE) regulates the activation of wild-type KIT and KIT mutants differently
por: Zhang, Shaoting, et al.
Publicado: (2021)

Cytokines secreted by bone marrow stromal cells protect c-KIT mutant AML cells from c-KIT inhibitor-induced apoptosis
por: Gordon, Peter M., et al.
Publicado: (2014)

Transcription Factor SCL Is Required for c-kit Expression and c-Kit Function in Hemopoietic Cells
por: Krosl, Gorazd, et al.
Publicado: (1998)

LMTK3 is essential for oncogenic KIT expression in KIT-mutant GIST and melanoma
por: Klug, Lillian R., et al.
Publicado: (2018)

Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors
por: Gao, Jing, et al.
Publicado: (2016)

A Fully Human Monoclonal Antibody Targeting cKIT Is a Potent Inhibitor of Pathological Choroidal Neovascularization in Mice
por: Seo, Songyi, et al.
Publicado: (2021)

Efficacy of SCF drug conjugate targeting c-KIT in gastrointestinal stromal tumor
por: Zhang, Dengyang, et al.
Publicado: (2022)

Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas
por: Satzger, I, et al.
Publicado: (2008)

Comparison of Thyroglobulin Measurements Using Three Different Immunoassay Kits: A BRAMHS Tg-Plus RIA Kit, a BRAMHS hTg Sensitive Kryptor Kit, and a Beckman Coulter ACCESS Immunoassay Kit
por: Kim, Mijin, et al.
Publicado: (2016)

Mammary tumor growth and metastasis are reduced in c‐Kit mutant Sash mice
por: He, Licai, et al.
Publicado: (2016)

Expression and Mutational Analysis of c-kit in Ovarian Surface Epithelial Tumors
por: Kim, Dong-Ja, et al.
Publicado: (2006)

Synergistic Targeting of DNA-PK and KIT Signaling Pathways in KIT Mutant Acute Myeloid Leukemia
por: Murray, Heather C., et al.
Publicado: (2023)

Interstitial cells of Cajal in W(sh)/W(sh) c-kit mutant mice
por: Iino, Satoshi, et al.
Publicado: (2020)

A promising hypothesis of c-KIT methylation/ expression paradox in c-KIT (+) squamous cell carcinoma of uterine cervix ----- CTCF transcriptional repressor regulates c-KIT proto-oncogene expression
por: Chang, Shih-Wen, et al.
Publicado: (2015)

Aging Kit Mutant Mice Develop Cardiomyopathy
por: Ye, Lei, et al.
Publicado: (2012)

c-KIT and c-KIT ligand (SCF) in synovial sarcoma (SS): an mRNA expression analysis in 23 cases
por: Tamborini, E, et al.
Publicado: (2001)

C-KIT-positive undifferentiated tumor of the liver: A case report
por: CHU, HYUN HEE, et al.
Publicado: (2014)

Inhibition of c-Kit signaling by diosmetin isolated from Chrysanthemum morifolium
por: Lee, Seong Jin, et al.
Publicado: (2013)

Expression of Epidermal c-Kit+ of Vitiligo Lesions Is Related to Responses to Excimer Laser
por: Park, Oun Jae, et al.
Publicado: (2016)

Role of c-Kit in Myocardial Regeneration and Aging
por: Marino, Fabiola, et al.
Publicado: (2019)

Analysis of parameters that affect human hematopoietic cell outputs in mutant c-kit-immunodeficient mice
por: Miller, Paul H., et al.
Publicado: (2017)

Evaluation of a New Immunochromatographic Assay Kit for the Rapid Detection of Norovirus in Fecal Specimens
por: Park, Kwi Sung, et al.
Publicado: (2012)

Disruption of c-Kit Signaling in Kit(W-sh/W-sh) Growing Mice Increases Bone Turnover
por: Lotinun, Sutada, et al.
Publicado: (2016)

Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death
por: Heo, Sook-Kyoung, et al.
Publicado: (2017)

The rat c-kit ligand, stem cell factor, induces c-kit receptor- dependent mouse mast cell activation in vivo. Evidence that signaling through the c-kit receptor can induce expression of cellular function
Publicado: (1992)

Evaluation of two commercial PRRSV antibody ELISA kits with samples of known status and singleton reactors
por: SEO, Byoung-Joo, et al.
Publicado: (2015)

Targeted Deep Sequencing Uncovers Cryptic KIT Mutations in KIT/PDGFRA/SDH/RAS-P Wild-Type GIST
por: Astolfi, Annalisa, et al.
Publicado: (2020)

The role of c-kit and imatinib mesylate in uveal melanoma
por: Pereira, Patricia Rusa, et al.
Publicado: (2005)

Expression and function of c-kit in hemopoietic progenitor cells
Publicado: (1991)

The usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesions
por: Pilloni, L., et al.
Publicado: (2011)

Selective RNAi-mediated inhibition of mutated c-kit
por: Ruano, Irene, et al.
Publicado: (2009)

c-kit(+) Cells Minimally Contribute Cardiomyocytes to the Heart
por: van Berlo, Jop H., et al.
Publicado: (2014)

C-Kit-Negative Gastrointestinal Stromal Tumor in the Stomach
por: Seo, Ho Seok, et al.
Publicado: (2015)

Loss of c-KIT expression in thyroid cancer cells
por: Franceschi, Sara, et al.
Publicado: (2017)

C-KIT Expression in Orbital Cavernous Venous Hemangiomas
por: Atallah, Mizhir, et al.
Publicado: (2021)

Flumatinib, a selective inhibitor of BCR-ABL/PDGFR/KIT, effectively overcomes drug resistance of certain KIT mutants
por: Zhao, Jie, et al.
Publicado: (2014)

Diagnostic evaluation of qRT-PCR-based kit and dPCR-based kit for COVID-19
por: Lee, Cherl-Joon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ndlcgovgo6a8e5vt7pauabaa8c